PharmaLogic Holdings Corp. announced the opening of a new positron emission tomography (PET) radiopharmaceutical manufacturing facility in Atlanta, Georgia, on April 28, 2026. The company, a contract development and manufacturing organization specializing in radiopharmaceuticals, said the site is part of a $250 million investment aimed at addressing the deficit of radiopharmaceutical infrastructure in the United States.
What it means
The Atlanta facility expands PharmaLogic’s production capacity for PET radiopharmaceuticals and provides resources for the research and development of novel agents. According to the company, the site will support the distribution of time-sensitive radiopharmaceuticals to hospitals and imaging centers in the Southeast and surrounding areas. Etienne Montagut, President & CEO of PharmaLogic, said the opening marks a critical step in the $250 million investment to address the U.S. infrastructure deficit and that the facility will serve as a hub for supporting the development of next-generation radiopharmaceuticals.
This addition follows recent openings by PharmaLogic in Cincinnati, Ohio; the Bronx, New York; Salt Lake City, Utah; and Los Angeles, California. The company operates more than 45 facilities across the U.S., Puerto Rico, Canada, and Norway. Its global network delivers over 2.5 million doses annually. PharmaLogic stated it is the world’s only cGMP-compliant CDMO currently manufacturing and distributing a commercial radiopharmaceutical therapeutic to more than 30 countries.
Key facts
- $250 million: Total investment amount to address U.S. radiopharmaceutical infrastructure deficit, according to the company.
- Atlanta, Georgia: Location of the new PET manufacturing facility.
- April 28, 2026: Date of the facility opening and announcement.
- Over 2.5 million doses: Annual delivery volume by PharmaLogic’s global network.
- 45+ facilities: Number of sites operated by PharmaLogic across the U.S., Puerto Rico, Canada, and Norway.
- 30+ countries: Number of nations receiving commercial radiopharmaceutical therapeutic from PharmaLogic.
- Cincinnati, Ohio; Bronx, New York; Salt Lake City, Utah; Los Angeles, California: Locations of recently opened PharmaLogic facilities.
Source: PharmaLogic Holdings Corp. news release (PR Newswire)